PT Jayamas Medica Industri Tbk (IDX:OMED)

Indonesia · Delayed Price · Currency is IDR

234.00

+6.00 (2.63%)

Aug 12, 2026, 2:35 PM WIB

27.87% (1Y)

Market Cap	6.16T +24.4%
Revenue (ttm)	2.30T +19.3%
Net Income	432.66B +30.5%
EPS	16.00 +30.7%
Shares Out	27.01B
PE Ratio	14.25
Forward PE	15.15
Dividend	4.08 (1.77%)
Ex-Dividend Date	Jun 18, 2026

Volume	28,190,000
Open	226.00
Previous Close	228.00
Day's Range	226.00 - 236.00
52-Week Range	180.00 - 318.00
Beta	0.07
Analysts	Buy
Price Target	283.00 (+20.94%)
Earnings Date	Aug 12, 2026

About IDX:OMED

PT Jayamas Medica Industri Tbk manufactures and sells medical devices in Indonesia, the United States of America, and South America. The company operates through three segments: Manufacturing, Distribution, and Retail. It offers medical disposables and consumables comprising medical gloves, syringes, masks, gauze, bandages, urine bag, foley catheter, alcoholic tissue, etc.; antiseptic and disinfectant fluids, povidone iodine, medical alcohol, Hdsol or blood cleansing liquid, etc.; and diagnostics and equipment, such as patient monitor, vital si... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 2000

Employees 1,340

Stock Exchange Indonesia Stock Exchange

Ticker Symbol OMED

Full Company Profile

Financial Performance

In 2025, IDX:OMED's revenue was 2.06 trillion, an increase of 9.44% compared to the previous year's 1.89 trillion. Earnings were 366.95 billion, an increase of 14.07%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for OMED stock is "Buy." The 12-month stock price target is Rp 283.00, which is an increase of 20.94% from the latest price.

Price Target

Rp 283.00

(20.94% upside)

Analyst Consensus: Buy

Stock Forecasts